| General Information of Drug Metabolite (DM) (ID: DM004170) |
| DM Name |
LU-AE58054 Metabolite M1
|
|
|
|
|
|
|
|
| Full List of Drug-Metabolizing Enzyme (DME) Related to This DM |
| DME(s) Producing This DM through Metabolism |
| DME Name |
DME ID |
Reactant |
Reaction |
Related Drug |
REF |
|
Cytochrome P450 2D6 (CYP2D6)
|
DME0009
|
| Unclear - Unclear |
LU-AE58054
|
[1] |
|
Cytochrome P450 3A4 (CYP3A4)
|
DME0001
|
| Unclear - Unclear |
LU-AE58054
|
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Full List of Drug(s) That Produce This DM By Metabolism |
| LU-AE58054 |
DR1883
|
Phase 3 |
Alzheimer disease |
|
|
| References |
| 1 |
Idalopirdine as a treatment for Alzheimer's disease. Expert Opin Investig Drugs. 2015;24(7):981-7.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
